Sort   by:  
 Page size 
UnknownRole of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial.
Not available
S-EPMC5134290 | biostudies-literature
UnknownPerspectives on cancer care in older patients in France.
Not available
S-EPMC7532034 | biostudies-literature
UnknownOne-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.
Not available
S-EPMC10252859 | biostudies-literature
UnknownSafety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial.
Not available
S-EPMC9100474 | biostudies-literature
UnknownNeoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.
Not available
S-EPMC4304382 | biostudies-literature
UnknownResponse to chemotherapy is not related to chromosome instability in synovial sarcoma.
Not available
S-EPMC4207728 | biostudies-literature
UnknownAssessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.
Not available
S-EPMC9291630 | biostudies-literature
UnknownRandomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Not available
S-EPMC8896060 | biostudies-literature
UnknownClinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Not available
S-EPMC10948524 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
Sort   by:  
 Page size